Published on
Participants discussed advancements in the mitochondrial medicine field, attended seminars, participated in team-building activities, and created further collaborative opportunities.
Published on
Three Frontier Programs (NeoCLD Program, Mitochondrial Medicine, and Pediatric Airway Disorders) have made world-changing discoveries, delivered lifesaving therapies, and provided exceptional care.
Published on
Several types of genetic alterations that affect mitochondria increase the risk of autism, two new studies suggest.
Published on
Systematic laboratory studies find some antioxidants should be tested in clinical trials as treatments for patients with mitochondrial disease.
Published on
Children with mitochondrial diseases who suffered acute metabolic strokes benefited from rapid IV treatment with the amino acid arginine, with no side effects.
Published on
Douglas Wallace, PhD, is considered the founder of mitochondrial genetics. His groundbreaking research at CHOP earned him two prestigious international awards in 2017.
Published on
Lacking effective drug treatments, patients with mitochondrial disease may use many vitamins and supplements — most of which are unregulated and untested.
Published on
Physicians who see patients with mitochondrial disease have a practical new tool: the first published care standards to guide clinical care.
Published on
The fall 2017 issue of Bench to Bedside featured Mitochondrial Medicine at Children's Hospital of Philadelphia and its Director, Marni Falk, MD.
Published on
Mitochondria, your cells’ power engines, could pay a key role in the development of autism spectrum disorder.